Request Info

AdAlta Limited

  • AdAlta is a highly innovative drug discovery and development company using its powerful technology platform to generate a promising new class of protein therapeutics, known as i-bodies, that have the potential to treat some of today’s most challenging medical conditions.
  • AdAlta's lead i-body product AD-214 is being developed for the treatment of lung fibrosis.